James Sissons

Title: The Innovative Contributions of James Sissons

Introduction

James Sissons is a notable inventor based in Seattle, WA (US), recognized for his significant contributions to the field of biotechnology. He holds 2 patents that focus on HPV-specific binding molecules, showcasing his expertise in developing innovative solutions for medical treatments.

Latest Patents

Sissons' latest patents involve the creation of binding molecules, including T-cell receptors (TCRs) and antibodies that specifically recognize human papilloma virus (HPV) 16, particularly the E6 and E7 proteins. These patents also encompass engineered cells that contain these binding molecules, as well as compositions and methods for treatment, which include the administration of these binding molecules and engineered cells. His work aims to enhance therapeutic strategies against HPV-related diseases.

Career Highlights

Throughout his career, James Sissons has worked with prominent companies in the biotechnology sector, including Juno Therapeutics GmbH and Editas Medicine, Inc. His experience in these organizations has contributed to his development of groundbreaking technologies and therapeutic approaches.

Collaborations

Sissons has collaborated with talented individuals in his field, including Cameron Brandt and Alexandra Croft. These partnerships have likely fostered innovation and the advancement of research in HPV treatment.

Conclusion

James Sissons stands out as an influential inventor in the biotechnology industry, with a focus on HPV-specific binding molecules. His patents and career achievements reflect his commitment to advancing medical science and improving patient outcomes.